| pubmed-article:21073953 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21073953 | lifeskim:mentions | umls-concept:C1101536 | lld:lifeskim |
| pubmed-article:21073953 | lifeskim:mentions | umls-concept:C0013081 | lld:lifeskim |
| pubmed-article:21073953 | lifeskim:mentions | umls-concept:C1332709 | lld:lifeskim |
| pubmed-article:21073953 | lifeskim:mentions | umls-concept:C0205263 | lld:lifeskim |
| pubmed-article:21073953 | lifeskim:mentions | umls-concept:C0332206 | lld:lifeskim |
| pubmed-article:21073953 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:21073953 | pubmed:dateCreated | 2010-12-27 | lld:pubmed |
| pubmed-article:21073953 | pubmed:abstractText | Blockade of T cell costimulatory molecules represents a promising new method of attenuating donor-reactive T cell responses to promote graft survival following transplantation. However, recent studies in murine models have shown the presence of an initial high frequency of naïve donor-reactive T cells may render this strategy ineffective. | lld:pubmed |
| pubmed-article:21073953 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21073953 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21073953 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21073953 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21073953 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21073953 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21073953 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21073953 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21073953 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21073953 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21073953 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21073953 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21073953 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21073953 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:21073953 | pubmed:issn | 1878-5492 | lld:pubmed |
| pubmed-article:21073953 | pubmed:author | pubmed-author:LarsenChristi... | lld:pubmed |
| pubmed-article:21073953 | pubmed:author | pubmed-author:FordMandy LML | lld:pubmed |
| pubmed-article:21073953 | pubmed:author | pubmed-author:StemporaLinda... | lld:pubmed |
| pubmed-article:21073953 | pubmed:copyrightInfo | Copyright © 2010 Elsevier B.V. All rights reserved. | lld:pubmed |
| pubmed-article:21073953 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21073953 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:21073953 | pubmed:volume | 24 | lld:pubmed |
| pubmed-article:21073953 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21073953 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21073953 | pubmed:pagination | 94-9 | lld:pubmed |
| pubmed-article:21073953 | pubmed:dateRevised | 2011-9-26 | lld:pubmed |
| pubmed-article:21073953 | pubmed:meshHeading | pubmed-meshheading:21073953... | lld:pubmed |
| pubmed-article:21073953 | pubmed:meshHeading | pubmed-meshheading:21073953... | lld:pubmed |
| pubmed-article:21073953 | pubmed:meshHeading | pubmed-meshheading:21073953... | lld:pubmed |
| pubmed-article:21073953 | pubmed:meshHeading | pubmed-meshheading:21073953... | lld:pubmed |
| pubmed-article:21073953 | pubmed:meshHeading | pubmed-meshheading:21073953... | lld:pubmed |
| pubmed-article:21073953 | pubmed:meshHeading | pubmed-meshheading:21073953... | lld:pubmed |
| pubmed-article:21073953 | pubmed:meshHeading | pubmed-meshheading:21073953... | lld:pubmed |
| pubmed-article:21073953 | pubmed:meshHeading | pubmed-meshheading:21073953... | lld:pubmed |
| pubmed-article:21073953 | pubmed:meshHeading | pubmed-meshheading:21073953... | lld:pubmed |
| pubmed-article:21073953 | pubmed:meshHeading | pubmed-meshheading:21073953... | lld:pubmed |
| pubmed-article:21073953 | pubmed:meshHeading | pubmed-meshheading:21073953... | lld:pubmed |
| pubmed-article:21073953 | pubmed:meshHeading | pubmed-meshheading:21073953... | lld:pubmed |
| pubmed-article:21073953 | pubmed:meshHeading | pubmed-meshheading:21073953... | lld:pubmed |
| pubmed-article:21073953 | pubmed:meshHeading | pubmed-meshheading:21073953... | lld:pubmed |
| pubmed-article:21073953 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21073953 | pubmed:articleTitle | CD28 blockade induces division-dependent downregulation of interleukin-2 receptor alpha. | lld:pubmed |
| pubmed-article:21073953 | pubmed:affiliation | Emory Transplant Center and Department of Surgery, Emory University, Atlanta, GA 30079, United States. mandy.ford@emory.edu | lld:pubmed |
| pubmed-article:21073953 | pubmed:publicationType | Journal Article | lld:pubmed |
